CEBPD and glioblastoma: The clinical significance of high levels of CEBPD in GBM was investigated demonstrating that the high expression of CEBPD predicted the poor prognosis of patients with GBM and LGGs (Fig. 2F; Supplementary Figure S2) in different datasets, and is an independent risk factor for patients with GBM (Supplementary Table S4).